Filtering promiscuous compounds in early drug discovery: is it a good idea?

Hajduk, 2011, Drug discovery: a question of library design, Nature, 470, 42, 10.1038/470042a Baell, 2010, New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays, J. Med. Chem., 53, 2719, 10.1021/jm901137j Baell, 2014, Chemistry: chemical con artists foil drug discovery, Nature, 513, 481, 10.1038/513481a Csermely, 2013, Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review, Pharmacol. Ther., 138, 333, 10.1016/j.pharmthera.2013.01.016 Medina-Franco, 2013, Shifting from the single to the multitarget paradigm in drug discovery, Drug Discov. Today, 18, 495, 10.1016/j.drudis.2013.01.008 Müller, 2003, Medicinal chemistry of target family-directed masterkeys, Drug Discov. Today, 8, 681, 10.1016/S1359-6446(03)02781-8 Reardon, 2013, Project ranks billions of drug interactions, Nature, 503, 449, 10.1038/503449a Merino, 2010, Drug profiling: knowing where it hits, Drug Discov. Today, 15, 749, 10.1016/j.drudis.2010.06.006 Swinney, 2011, How were new medicines discovered?, Nat. Rev. Drug Discov., 10, 507, 10.1038/nrd3480 Eder, 2014, The discovery of first-in-class drugs: origins and evolution, Nat. Rev. Drug Discov., 13, 577, 10.1038/nrd4336 Congreve, 2005, Structural biology and drug discovery, Drug Discov. Today, 10, 895, 10.1016/S1359-6446(05)03484-7 Reymond, 2012, Exploring chemical space for drug discovery using the chemical universe database, ACS Chem. Neurosci., 3, 649, 10.1021/cn3000422 Reymond, 2015, The chemical space project, Acc. Chem. Res., 48, 722, 10.1021/ar500432k Macarron, 2015, Chemical libraries: how dark is HTS dark matter?, Nat. Chem. Biol., 11, 904, 10.1038/nchembio.1937 Neves, 2013, Exploring the DNA binding/cleavage, cellular accumulation and topoisomerase inhibition of 2-hydroxy-3-(aminomethyl)-1,4-naphthoquinone Mannich bases and their platinum(II) complexes, J. Inorg. Biochem., 119, 54, 10.1016/j.jinorgbio.2012.10.007 Cardoso, 2014, Synthesis and evaluation of the cytotoxic activity of 1,2-furanonaphthoquinones tethered to 1,2,3-1H-triazoles in myeloid and lymphoid leukemia cell lines, Eur. J. Med. Chem., 84, 708, 10.1016/j.ejmech.2014.07.079 Parkinson, 2013, Efficient NQO1 substrates are potent and selective anticancer agents, ACS Chem. Biol., 8, 2173, 10.1021/cb4005832 Li, 2014, Mechanistic studies of cancer cell mitochondria- and NQO1-mediated redox activation of beta-lapachone, a potentially novel anticancer agent, Toxicol. Appl. Pharmacol., 281, 285, 10.1016/j.taap.2014.10.012 Parkinson, 2015, Deoxynyboquinones as NQO1-activated cancer therapeutics, Acc. Chem. Res., 48, 2715, 10.1021/acs.accounts.5b00365 Goel, 2008, Multi-targeted therapy by curcumin: how spicy is it?, Mol. Nutr. Food Res., 52, 1010, 10.1002/mnfr.200700354 Hatcher, 2008, Curcumin: from ancient medicine to current clinical trials, Cell. Mol. Life Sci., 65, 1631, 10.1007/s00018-008-7452-4 Feng, 2005, High-throughput assays for promiscuous inhibitors, Nat. Chem. Biol., 1, 146, 10.1038/nchembio718 Macarron, 2011, Impact of high-throughput screening in biomedical research, Nat. Rev. Drug Discov., 10, 188, 10.1038/nrd3368 Feng, 2006, A detergent-based assay for the detection of promiscuous inhibitors, Nat. Protoc., 1, 550, 10.1038/nprot.2006.77 Wassermann, 2015, Dark chemical matter as a promising starting point for drug lead discovery, Nat. Chem. Biol., 11, 958, 10.1038/nchembio.1936 Stumpfe, 2014, Recent progress in understanding activity cliffs and their utility in medicinal chemistry, J. Med. Chem., 57, 18, 10.1021/jm401120g Duarte, 2007, Privileged structures: a useful concept for the rational design of new lead drug candidates, Mini Rev. Med. Chem., 7, 1108, 10.2174/138955707782331722 Maia, 2014, Acylhydrazone derivatives: a patent review, Expert Opin. Ther. Pat., 24, 1161, 10.1517/13543776.2014.959491 Alves, 2009, From nature to drug discovery: the indole scaffold as a ‘privileged structure’, Mini Rev. Med. Chem., 9, 782, 10.2174/138955709788452649